Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases von Dasari, Arvind, Mehta, Kathan, Byers, Lauren A., Sorbye, Halfdan, Yao, James C.

Volltext

Gastroenteropancreatic high‐grade neuroendocrine carcinoma von Sorbye, Halfdan, Strosberg, Jonathan, Baudin, Eric, Klimstra, David S., Yao, James C.

Volltext

Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study von Halperin, Daniel M, MD, Shen, Chan, PhD, Dasari, Arvind, MD, Xu, Ying, MS, Chu, Yiyi, MS, Zhou, Shouhao, PhD, Shih, Ya-Chen Tina, Prof, Yao, James C, Prof

Volltext

Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed? von OVERMAN, Michael J, MODAK, Janhavi, KOPETZ, Scott, MURTHY, Ravi, YAO, James C, HICKS, Marshall E, ABBRUZZESE, James L, TAM, Alda L

Volltext

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study von Yao, James C, Dr, Fazio, Nicola, MD, Singh, Simron, MD, Buzzoni, Roberto, MD, Carnaghi, Carlo, MD, Wolin, Edward, MD, Tomasek, Jiri, MD, Raderer, Markus, MD, Lahner, Harald, MD, Voi, Maurizio, MD, Pacaud, Lida Bubuteishvili, MD, Rouyrre, Nicolas, MSc, Sachs, Carolin, RN, Valle, Juan W, MD, Fave, Gianfranco Delle, MD, Van Cutsem, Eric, MD, Tesselaar, Margot, MD, Shimada, Yasuhiro, MD, Oh, Do-Youn, MD, Strosberg, Jonathan, MD, Kulke, Matthew H, MD, Pavel, Marianne E, MD

Volltext

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study von Yao, James C, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Voi, Maurizio, Brandt, Ulrike, He, Wei, Chen, David, Capdevila, Jaume, de Vries, Elisabeth G E, Tomassetti, Paola, Hobday, Timothy, Pommier, Rodney, Öberg, Kjell

Volltext

Thymic Neuroendocrine Tumors: A SEER Database Analysis of 160 Patients von GAUR, Puja, LEARY, Colleen, YAO, James C

Volltext

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-control... von Pavel, Marianne E, Prof, Hainsworth, John D, Prof, Baudin, Eric, MD, Peeters, Marc, Prof, Hörsch, Dieter, Prof, Winkler, Robert E, MD, Klimovsky, Judith, MD, Lebwohl, David, MD, Jehl, Valentine, MSc, Wolin, Edward M, MD, Öberg, Kjell, Prof, Van Cutsem, Eric, Prof, Yao, James C, Dr

Volltext

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial von Yao, James C, Lombard-Bohas, Catherine, Baudin, Eric, Kvols, Larry K, Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, St Peter, Jessica, Haas, Tomas, Lebwohl, David, Van Cutsem, Eric, Kulke, Matthew H, Hobday, Timothy J, O'Dorisio, Thomas M, Shah, Manisha H, Cadiot, Guillaume, Luppi, Gabriele, Posey, James A, Wiedenmann, Bertram

Volltext

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States von YAO, James C, HASSAN, Manal, EVANS, Douglas B, PHAN, Alexandria, DAGOHOY, Cecile, LEARY, Colleen, MARES, Jeannette E, ABDALLA, Eddie K, FLEMING, Jason B, VAUTHEY, Jean-Nicolas, RASHID, Asif

Volltext

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211) von Kunz, Pamela L, Graham, Noah T, Catalano, Paul J, Nimeiri, Halla S, Fisher, George A, Longacre, Teri A, Suarez, Carlos J, Martin, Brock A, Yao, James C, Kulke, Matthew H, Hendifar, Andrew E, Shanks, James C, Shah, Manisha H, Zalupski, Mark M, Schmulbach, Edmond L, Reidy-Lagunes, Diane L, Strosberg, Jonathan R, O'Dwyer, Peter J, Benson, 3rd, Al B

Volltext

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis von Fazio, Nicola, Buzzoni, Roberto, Delle Fave, Gianfranco, Tesselaar, Margot E., Wolin, Edward, Van Cutsem, Eric, Tomassetti, Paola, Strosberg, Jonathan, Voi, Maurizio, Bubuteishvili‐Pacaud, Lida, Ridolfi, Antonia, Herbst, Fabian, Tomasek, Jiri, Singh, Simron, Pavel, Marianne, Kulke, Matthew H., Valle, Juan W., Yao, James C.

Volltext

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors von Strosberg, Jonathan R, Halfdanarson, Thorvardur R, Bellizzi, Andrew M, Chan, Jennifer A, Dillon, Joseph S, Heaney, Anthony P, Kunz, Pamela L, O'Dorisio, Thomas M, Salem, Riad, Segelov, Eva, Howe, James R, Pommier, Rodney F, Brendtro, Kari, Bashir, Mohammad A, Singh, Simron, Soulen, Michael C, Tang, Laura, Zacks, Jerome S, Yao, James C, Bergsland, Emily K

Volltext

Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b von YAO, James C, PHAN, Alexandria, HOFF, Paulo M, CHEN, Helen X, CHARNSANGAVEJ, Chusilp, YEUNG, Sai-Ching J, HESS, Kenneth, NG, Chaan, ABBRUZZESE, James L, AJANI, Jaffer A

Volltext

Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ von Liu, Yi, Deguchi, Yasunori, Wei, Daoyan, Liu, Fuyao, Moussalli, Micheline J., Deguchi, Eriko, Li, Donghui, Wang, Huamin, Valentin, Lovie Ann, Colby, Jennifer K., Wang, Jing, Zheng, Xiaofeng, Ying, Haoqiang, Gagea, Mihai, Ji, Baoan, Shi, Jiaqi, Yao, James C., Zuo, Xiangsheng, Shureiqi, Imad

Volltext

Victor M. Bernhard, MD, 1927-2020 von Yao, James S.T., Gregory, Roger T., McCarthy, Walter J.

Volltext

EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms von Kiyasu, Yoshiyuki, Zuo, Xiangsheng, Liu, Yi, Yao, James C., Shureiqi, Imad

Volltext

Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting von KULKE, Matthew H, SIU, Lillian L, VAN CUTSEM, Eric, PINGPANK, James, OBERG, Kjell, COHEN, Steven J, POSNER, Mitchell C, YAO, James C, TEPPER, Joel E, FISHER, George, JAFFE, Deborah, HALLER, Daniel G, ELLIS, Lee M, BENEDETTI, Jacqueline K, BERGSLAND, Emily K, HOBDAY, Timothy J

Volltext

Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study von YAO, James C, PHAN, Alexandria T, MERIC-BERNSTAM, Funda, CHANG, David Z, WOLFF, Robert A, HESS, Kenneth, GUPTA, Sanjay, JACOBS, Carmen, MARES, Jeannette E, LANDGRAF, Andrea N, RASHID, Asif

Volltext

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study von Phan, Alexandria T, MD, Halperin, Daniel M, MD, Chan, Jennifer A, MD, Fogelman, David R, MD, Hess, Kenneth R, Prof, Malinowski, Paige, BA, Regan, Eileen, MSN, Ng, Chaan S, Prof, Yao, James C, Prof, Kulke, Matthew H, MD

Volltext